Cancer cells and CSCs often have constitutively activated transcription factor NF-κB that promotes expression levels of apoptosis inhibitory proteins and drug resistantance proteins and provides enhanced survival and resistance to therapies in cancer cells. Here, NFKB1 is linked to cancer.